Vinay Prasad is returning to his role overseeing vaccine, gene therapy and blood product regulation at the U.S. Food and Drug ...

Less than weeks after stepping down, Prasad will return to lead CBER “at the FDA’s request,” according to an HHS spokesperson ...

Ukraine and its European allies sought on Sunday to present a united front ahead of a meeting this week between President ...

It turns out that some of our DNA — about 8% — are the remnants of ancient viruses that embedded themselves into our genetic ...

Vinay Prasad, a former critic of U.S. COVID-19 policies, returns to the FDA's Center for Biologics Evaluation and Research after briefly leaving. His tenure drew criticism, notably over the handling ...

Prasad, a physician who was first appointed to the role in May, left the FDA on July 30 following pressure from Loomer and ...

Dr. Vinay Prasad had resigned as the FDA's chief medical and scientific officer in late July after influential Trump allies ...

T O APPRECIATE the dilemmas the Food and Drug Administration (FDA) faces when it reviews new drugs targeting rare diseases, ...

Vinay Prasad, a top vaccine regulator ousted from the Food and Drug Administration (FDA) late last month, is set to return to ...